- Winner of 2025 CPHI Pharma Award for Manufacturing Excellence
- Making $40/gram possible.
- Biologics innovation begins with Enzene.
- The new face of CIDMO is Enzene.
- A Continuously Innovative Development & Manufacturing Organization
- Candor, Innovation, Respect, Excellence, Entrepreneurship, Integrity
- We are Enzene.
Problems we solve
With years of technical expertise and a platform that pushes your projects further, your progress is our priority.
Licensing
Who is Enzene?
We are a global CDMO dedicated to impacting
the global healthcare landscape by bringing
trusted and affordable medicines to market, quickly.
Committed to innovation, we have revolutionized biologics production with our patented and validated continuous bioprocess manufacturing platform, EnzeneX™, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Our fully-integrated services and productive pipeline of biosimilars are designed to cater to your project’s every need.
Biosimilars: A comparability study
A customer approached Enzene Biosciences to complete comparability testing, focusing on the comparison of the physiochemical and biological properties of a biosimilar monoclonal antibody (mAb) drug product to the reference medicinal product (RMP). Find out how we helped them achieve success.
The future begins now
Your biologic deserves the most technologically advanced manufacturing process in the industry. And you deserve a new way to think about strategic partnership. Today is just the beginning.